Fcl Fineotex Chemical Limited
Total Page:16
File Type:pdf, Size:1020Kb
FINEOTEX® A Speciality Chemical Producing Public Listed Company cS) LD ge £1 Cg, ate, & y eer ey 1SO 14001 54 gq0® 13" February, 2020 To, General Manager, The Manager, Listing Department, Listing & Compliance Department BSE Limited, The National Stock Exchange of India Limited P.J. Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai — 400 001 Bandra East, Mumbai — 400051 Company code: 533333 Company code: FCL Dear Sirs/Madam, Subject:- Regulation 30, Schedule III Part A (15) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 With reference to the above caption subject, we enclose Earning Presentation for the quarter and Nine Months ended 31% December, 2019 requesting you to kindly take this in your record. Kindly acknowledge receipt of the same. Thanking You, Yours faithfully, For FINEOTEX CHEMICAL LIMITED Hemant Auti (Company Secretary) FCL FINEOTEX CHEMICAL LIMITED 42 & 43, Manorama Chambers, $.V. Road, Bandra (West), Mumbai - 400 050. India. Phone : (+91-22) 2655 9174/75/76/77 INDIA @ MALAYSIA Fax : (+91-22) 2655 9178 E-mail : [email protected] Website : www.fineotex.com CIN - L24100MH2004PLC144295 FINEOTEX CHEMICAL LIMITED 9M / Q3- FY20 Where Dependability Counts… EARNINGS PRESENTATION EXECUTIVE SUMMARY 2 FINEOTEX® EXECUTIVE SUMMARY OVERVIEW BUSINESS MIX KEY STRENGTHS FY19 FINANCIALS (I-GAAP-Consolidated) . Fineotex Group founded in 1979 . Fineotex is one of India’s largest . Strong Balance Sheet with Zero Income – INR 1,823 MN; CAGR 3 is engaged in manufacturing of and most progressive speciality Debt; High ROE and ROCE, Years 19% . Specialty Chemicals and Enzymes. textile chemical manufacturers. Consistently Dividend paying. EBITDA – INR 346 MN; CAGR 3 . Mr. Surendra Kumar Tibrewala is . The Company manufactures . Professionally run company with Years 9% . Chairman & MD and Mr Sanjay chemicals for the entire value high Promoter holding. Promoter PAT – INR 243 MN; CAGR 3 Years Tibrewala Executive Director & chain for the textile industry stake is the same as last year. 13% CFO. including pretreatment, dyeing , . Strong Industry knowledge – over . The company has manufacturing printing and finishing process . three decades of operations . facilities in Navi Mumbai and . The company also manufactures . Low cost high margin products Malaysia with a combined other chemicals for various with high entry barriers. production capacity of 43,000 industries like agro , adhesives , . Extremely strong brand loyalty. MT/p.a. construction, water treatment . Strong R&D capabilities help them . Current Market Capitalization is etc. increase customization levels of INR 2999.5 MN as of 31st . It has more than 400 products their products. December, 2019. catering to various industries. 3 COMPANY OVERVIEW 4 FINEOTEX® COMPANY OVERVIEW . Fineotex Group was established in 1979 by Mr. Surendra Industry wise Revenue Domestic Revenue Tibrewala. Break-up Break-up Adhesives Other . FCL was incorporated as a public limited company in 2007. The 1% East Chemicals South Fertilizer 2% company was listed on Bombay Stock Exchange in March 2011, Chemicals 1% 20% and listed on the National Stock Exchange in January 2015. 1% North 40% . Fineotex is one of India’s largest and most progressive specialty Textile West textile chemical manufacturers. Chemicals 38% 97% . The company manufactures over 400 specialty chemicals and enzymes to Textile, Garment, Construction, Leather, Water treatment , Agrochemicals, Adhesives and others industries. Geographical Revenue Geographical Revenue Break-up (Standalone) Break-up (Consolidated) . Headquartered in Mumbai, it has manufacturing facilities in India and Malaysia with a combined production capacity of 43,000MT/p.a. Export 25% Domestic . It has a global presence across 60 countries and caters to well Overseas 48% known companies in India and overseas. Domestic 52% 75% . FCL along with it’s subsidiary Biotex Malaysia, has a global presence as a reputed producer of specialty chemicals. 5 FINEOTEX® ACCREDITATIONS SA 8000 (Social Accountability ISO 9001:20015 ISO 14001:2015 OHSAS 18001:2007 Management System) Fastest growing company in chemical Recognized as a ZDHC (Zero Discharge Hazardous Chemical) manufacturing by IPF at Bombay Stock Star Export House Exchange 6 FINEOTEX® ACCREDITATIONS 7 FINANCIAL OVERVIEW 8 FINEOTEX® 9M / Q3-FY20 FINANCIAL HIGHLIGHTS Q3-FY20 performance (Standalone): Q3-FY20 performance (Consolidated): • Revenue : INR 326 Mn; Growth of 15.6% YoY • Revenue : INR 521 Mn; Growth of 13.3% YoY • EBITDA : INR 63 Mn • EBITDA : INR 81 Mn. • Net Profit : INR 67 Mn ; Growth of 48.9% YoY • Net Profit : INR 81 Mn ; Growth of 28.6% YoY • Diluted EPS : INR 0.60 per share • Diluted EPS : INR 0.73 per share 9M-FY20 performance (Standalone): 9M-FY20 performance (Consolidated): • Revenue : INR 984 Mn; Growth of 22.5% YoY • Revenue : INR 1,528 Mn; Growth of 15.7% YoY • EBITDA : INR 214 Mn. • EBITDA : INR 266 Mn. • Net Profit : INR 174 Mn. Growth of 47.5% YoY • Net Profit : INR 204 Mn. Growth of 14.6% YoY • Diluted EPS : INR 1.56 per share • Diluted EPS : INR 1.84 per share 9 FINEOTEX® QUARTERLY- INCOME STATEMENT STANDALONE INCOME STATEMENT (INR Mn) Q3-FY20 Q3-FY19 Y-o-Y Q2-FY20 Q-o-Q Revenue 326 282 15.6% 332 (1.8)% Expenses 263 224 17.4% 252 4.4% EBITDA 63 58 8.6% 80 (21.3)% Other Income 29 6 NA 3 NA Depreciation 3 2 50.0% 3 NA Finance Cost 1 1 NA 1 NA Exceptional Items - - NA - NA PBT 88 61 44.3% 79 11.4% Tax 21 16 31.3% 19 10.5% PAT 67 45 48.9% 60 11.7% Other Comprehensive Income - - NA - NA Total Comprehensive Income 67 45 48.9% 60 11.7% Diluted EPS (INR) 0.60 0.41 46.3% 0.54 11.1% 10 FINEOTEX® NINE MONTHLY- INCOME STATEMENT STANDALONE INCOME STATEMENT (INR Mn) 9M-FY20 9M-FY19 Y-o-Y Revenue 984 803 22.5% Expenses 770 618 24.6% EBITDA 214 185 15.7% EBITDA Margins (%) 21.75% 23.04% (129) Bps Other Income 30 - NA Depreciation 8 7 14.3% Finance Cost 2 5 (60.0)% Exceptional Items - (4) NA PBT 234 169 38.5% Tax 60 51 17.6% PAT 174 118 47.5% PAT Margins (%) 17.68% 14.69% 299 Bps Other Comprehensive Income - - NA Total Comprehensive Income 174 118 47.5% Diluted EPS (INR) 1.56 1.06 47.2% 10 FINEOTEX® QUARTERLY- INCOME STATEMENT CONSOLIDATED INCOME STATEMENT (INR Mn) Q3-FY20 Q3-FY19 Y-o-Y Q2-FY20 Q-o-Q Revenue 521 460 13.3% 510 2.2% Expenses 440 375 17.3% 408 7.8% EBITDA 81 85 (4.7)% 102 (20.6)% Other Income 31 5 NA (7) NA Depreciation 3 3 NA 3 NA Finance Cost 2 2 NA 2 NA Exceptional Items - - NA - NA PBT 107 85 25.9% 90 18.9% Tax 26 22 18.2% 24 8.3% PAT 81 63 28.6% 66 22.7% Other Comprehensive Income - - NA - - Total Comprehensive Income 81 63 28.6% 66 22.7% Diluted EPS (INR) 0.73 0.57 28.1% 0.59 23.7% 11 FINEOTEX® NINE MONTHLY- INCOME STATEMENT CONSOLIDATED INCOME STATEMENT (INR Mn) 9M-FY20 9M-FY19 Y-o-Y Revenue 1,528 1,321 15.7% Expenses 1,262 1,061 18.9% EBITDA 266 260 2.3% EBITDA Margins (%) 17.41% 19.68% 227 Bps Other Income 24 1 NA Depreciation 8 7 14.3% Finance Cost 5 7 (28.6)% Exceptional Items - (4) NA PBT 277 243 14.0% Tax 73 65 12.3% PAT 204 178 14.6% PAT Margins (%) 13.35% 13.47% (12)Bps Other Comprehensive Income - - NA Total Comprehensive Income 204 178 14.6% Diluted EPS (INR) 1.84 1.60 15.0% 12 FINEOTEX® HISTORICAL STANDALONE INCOME STATEMENT INCOME STATEMENT (INR Mn) FY14 FY15 FY16 FY17 FY18 FY19 9M-FY20 Revenue 535 650 681 757 919 1,126 984 Expenses 486 537 498 565 683 869 770 EBITDA 49 113 183 192 236 257 214 Other Income 37 48 45 44 75 12 30 Depreciation 2 4 5 6 6 9 8 Finance Cost 3 3 3 3 4 6 2 Extra-Ordinary Items (1) - - - - (5) - PBT 80 154 220 227 301 249 234 Tax 22 42 69 68 89 76 60 Operational PAT* 20 64 106 115 138 156 144 PAT 58 112 151 159 213 173 174 Diluted EPS (INR) 2.59 1.00 1.35 1.43 1.91 1.56 1.56 *Operational PAT= PAT- Other Income + Extraordinary items 12 FINEOTEX® STANDALONE BALANCE SHEET PARTICULARS (INR Mn) FY 13 FY14 FY 15 FY16 FY17 PARTICULARS (INR Mn) FY 13 FY14 FY15 FY16 FY17 EQUITIES & LIABILITIES ASSETS Shareholder Funds 546 601 707 837 956 Non Current Assets 225 244 576 678 772 (A) Share Capital 112 112 224 225 223 (A) Fixed Assets 63 68 106 120 163 (B) Reserves& Surplus 434 489 483 612 733 (B) Non-current Investments 84 93 385 484 532 (C) Long term Loans & (C) Share Application Money - - - - - 73 79 80 69 73 Advances Non Current Liabilities 33 7 - - - (D) Other Non Current Assets 5 4 5 5 4 (A) Long Term Borrowings 33 7 - - - Current Assets 464 516 272 292 311 Current Liabilities 110 152 141 133 127 (A)Inventories 42 59 47 57 65 (A) Short term Borrowings 2 - 10 30 10 (B) Trade Receivables 114 171 169 192 208 (B) Trade Payables 72 111 96 99 112 (C) Cash & Bank Balances 91 82 27 28 17 (D) Short-term loans & (C) Other Current Liabilities 29 34 12 3 4 3 35 20 14 17 advances (D) Short-term provisions 7 7 23 1 1 (E) Other current assets 214 169 9 1 4 GRAND TOTAL - EQUITIES & 689 760 848 970 1,083 GRAND TOTAL – ASSETS 689 760 848 970 1,083 LIABILITES 13 FINEOTEX® STANDALONE BALANCE SHEET PARTICULARS (INR Mn) FY18 FY19 H1-FY20 PARTICULARS (INR Mn) FY18 FY19 H1-FY20 EQUITIES & LIABILITIES ASSETS Shareholder Funds Non Current Assets Equity Share Capital 223 223 223 Property, Plant & Equipment 180 247 286 Other Equity 988 1,161 1,257 Capital work-in-progress - - 3 Investment in Property 38 38 38 Investment in subsidiaries - - - Non Current Liabilities Financial Assets Financial Liabilities (i) Investments 626 526 558 (i) Borrowings 2 1 - (ii) Loans & Advances - - - (ii) Other Financial Liabilities 4 5 4 (iii) Others 30 33 30 Provisions - - - Deferred tax assets (net) 2 - - Deferred Tax Liability - 2 5 Non-Current Tax Assets 4 8 9 Other Non